Catalio Capital Management

Venture Capital Active United States
Last updated 2026-06-18
Portfolio
3
in our dataset
Rounds participated
3
Rounds led
0
Rounds' value
$288.0M
total disclosed, rounds participated
Stages

Portfolio · 3

Investment activity

Portfolio by sector

Health Tech & Life Sciences3

Q&A

What is Catalio Capital Management's primary investment focus?
Catalio Capital Management primarily focuses on the Health Tech & Life Sciences sector, with all three of its listed portfolio companies operating in this area.
Can you name some of Catalio Capital Management's portfolio companies?
Catalio Capital Management's portfolio includes Immunai, which specializes in peripheral tissue analysis, and Insightec, known for MR-guided focused ultrasound systems.
What was Catalio Capital Management's most recent investment?
Catalio Capital Management participated in a G Round for Insightec in October 2024, which raised a total of $592.9M.
When did Catalio Capital Management make its investment in Immunai?
Catalio Capital Management invested in Immunai's B Round in February 2021, a round that raised $295M.
What is the typical investment range for Catalio Capital Management?
Catalio Capital Management's investment range is between $60M and $150M.
Has Catalio Capital Management made any investments in 2024?
Yes, Catalio Capital Management made two investments in 2024: a D Round for Orasis Pharmaceuticals in June and a G Round for Insightec in October.
Which funding stages does Catalio Capital Management typically participate in?
Catalio Capital Management has participated in A, D, and G funding rounds, according to its investment history.